Clinical Validation of the Withings ECG Monitor for the Detection of Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 274 participants.

Also called NCT05266235

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 274 participants (enrolled count) (from the registry)
Sponsor
  • Withings Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05266235
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05266235. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-04-14 (actual); primary completion 2022-07-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Validation of the Withings ECG Monitor for the Detection of Atrial Fibrillation
Acronym
QDA-UE
Intervention (Device)
Validation of the Withings bodyscan scale WBS08
Lead sponsor
Withings (class: industry)

Record details

Record id
cardio:ct-nct05266235
Content hash
da889bd18e1ac0ff01bbd543f26836fd5f4e0b3f220e0a7fc4f07a9364b6b4b2